McElhaugh Michael J. - Insider Non-Derivative Transactions at Arbutus Biopharma Corp (ABUS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 14, 2025, McElhaugh Michael J.'s relationship to Arbutus Biopharma Corp (ABUS) is Director,Officer (Interim President & CEO), and currently has 1,658,003 shares of Common Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ABUS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

McElhaugh Michael J. - Insider Non-Derivative Transactions of ABUS Common Shares

McElhaugh Michael J. - Insider Non-Derivative Transactions at ABUS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 15, 2025	Acquisition -- (Common Shares)	177000	0	1658003
Feb 5, 2025	Sell -- (Common Shares)	23790	3.28	1481003
Feb 3, 2024	Sell -- (Common Shares)	10164	2.31	1504793
Feb 2, 2024	Acquisition -- (Common Shares)	123800	0	1514957
Feb 2, 2023	Acquisition -- (Common Shares)	83700	0	1391157